Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$20.80 -$0.63 -2.9%
Price as of February 25, 2020, 4:30 p.m. EST View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Interactive Chart


News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings










3 Monster Stocks in the Making

Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.